Baxter Healthcare Corporation recalled 125,496 bottles of Sterile Water for Irrigation on December 22, 2025. Plastic particles from the bottle rim contaminated the solution, posing a health risk. Consumers and healthcare providers must stop using the product immediately and seek guidance.
Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
Consumers and healthcare providers should stop using this product immediately. Contact Baxter Healthcare Corporation or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recall affects Sterile Water for Irrigation, 250 mL, packaged in a single-dose plastic bottle. The affected lot number is G171359, with an expiration date of 05/31/2027. The product was distributed nationwide.
The recall stems from the presence of plastic particles observed floating in the sterile water. These particles pose a health risk if used in medical procedures.
As of the report date, no injuries or adverse events have been documented related to this recall. The contamination risk is classified as high due to potential health implications.
Stop using the product immediately. Consumers and healthcare providers should contact Baxter Healthcare Corporation or consult with healthcare providers for further guidance.
For more information, call Baxter Healthcare Corporation at 1-800-XXX-XXXX or visit their website at www.baxter.com.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.